Of note, in the combination treatment groups (HH044 + anti-PD-1 and MAC-3-190 + anti-PD-1), the tumor growth was significantly slower compared with the control mice, and the responses for each treatment within the same group were consistent. The gene discussed is PDCD1; the disease is neoplasm.